Journal of Andrology Testis Workshop 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Traish, A. M.
Right arrow Articles by Goldstein, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Traish, A. M.
Right arrow Articles by Goldstein, I.
Journal of Andrology, Vol. 24, No. 3, May/June 2003
Copyright © American Society of Andrology

Effects of Medical or Surgical Castration on Erectile Function in an Animal Model

ABDULMAGED M. TRAISH*,{dagger}, RICARDO MUNARRIZ*, LUKE O'CONNELL*, SEONG CHOI*, SOO WOONG KIM*, NOEL N. KIM*, YUE-HUA HUANG* AND IRWIN GOLDSTEIN*

From the Departments of * Urology and{dagger} Biochemistry, Boston University School of Medicine, Boston, Massachusetts.

Correspondence to: Dr Abdulmaged M. Traish, Department of Urology, Boston University School of Medicine, 700 Albany Street, Room W607, Boston, MA 02118 (e-mail: atraish{at}bu.edu).


The goal of this study was to investigate the effects of medical castration (luteinizing hormone-receptor hormone [LH-RH] agonist treatment) or surgical castration on erectile function in an animal model. New Zealand White male rabbits were either kept intact (control); surgically orchiectomized; or treated for 2, 4, or 8 weeks with the LH-RH agonist leuprolide acetate (107 µg/kg/mo). At 2 weeks, plasma testosterone levels of orchiectomized and leuprolide acetate–treated animals were 12.8% and 57.4% of intact control animals, respectively. Erectile function was assessed by continuously recording systemic arterial pressure (SAP) and intracavernosal blood pressure (ICP) and determining the ICP:SAP ratios in response to electrical stimulation of the pelvic nerve at varying frequencies (2.5–32 Hz). Androgen deprivation by surgical (orchiectomy) or medical (leuprolide acetate) castration reduced ICP at all frequencies tested but did not alter SAP. Administration of the phosphodiesterase type 5 inhibitor vardenafil (10 µg/kg) did not enhance ICP in surgically orchiectomized or leuprolide acetate–treated animals. Nitric oxide synthase and arginase activities in the corpus cavernosum were not significantly altered by surgical or medical castration. Further, Masson trichrome staining of erectile tissue from androgen-ablated animals showed a reduction in smooth muscle content. These data demonstrate that androgen deprivation achieved by surgical or medical castration adversely affects penile hemodynamics and erectile function without producing significant changes in the activities of nitric oxide synthase or arginase. We conclude that androgen deprivation produces structural alterations in the corpus cavernosum leading to corporal veno-occlusive dysfunction.

     Key words: Androgens, trabecular smooth muscle, corpus cavernosum, veno-occlusion, vardenafil, leuprolide acetate




This article has been cited by other articles:


Home page
Therapeutic Advances in UrologyHome page
A. Aversa, R. Bruzziches, D. Francomano, M. Natali, and A. Lenzi
Testosterone and phosphodiesterase type-5 inhibitors: new strategy for preventing endothelial damage in internal and sexual medicine?
Therapeutic Advances in Urology, October 1, 2009; 1(4): 179 - 197.
[Abstract] [PDF]


Home page
J AndrolHome page
A. M. Traish
Androgens Play a Pivotal Role in Maintaining Penile Tissue Architecture and Erection: A Review
J Androl, July 1, 2009; 30(4): 363 - 369.
[Abstract] [Full Text] [PDF]


Home page
J AndrolHome page
A. A. Yassin and F. Saad
Testosterone and Erectile Dysfunction
J Androl, November 1, 2008; 29(6): 593 - 604.
[Abstract] [Full Text] [PDF]


Home page
J AndrolHome page
O. Canguven and A. L. Burnett
The Effect of 5 {alpha}-Reductase Inhibitors on Erectile Function
J Androl, September 1, 2008; 29(5): 514 - 523.
[Abstract] [Full Text] [PDF]


Home page
J AndrolHome page
W.-Y. Lin, A. Mannikarottu, P. Chichester, A. Guven, A. Johnson, P. Neuman, Y.-S. Juan, C. Schuler, B. Kogan, and R. M. Levin
Changes in the Smooth Muscle of the Corpora Cavernosum Related to Reversal of Partial Bladder Outlet Obstruction in Rabbits
J Androl, March 1, 2008; 29(2): 164 - 171.
[Abstract] [Full Text] [PDF]


Home page
J AndrolHome page
A. L. Burnett
Molecular Pharmacotherapeutic Targeting of PDE5 for Preservation of Penile Health
J Androl, January 1, 2008; 29(1): 3 - 14.
[Abstract] [Full Text] [PDF]


Home page
J AndrolHome page
A. M. Traish, P. Toselli, S.-J. Jeong, and N. N. Kim
Adipocyte Accumulation in Penile Corpus Cavernosum of the Orchiectomized Rabbit: A Potential Mechanism for Veno-occlusive Dysfunction in Androgen Deficiency
J Androl, March 1, 2005; 26(2): 242 - 248.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. Morelli, S. Filippi, R. Mancina, M. Luconi, L. Vignozzi, M. Marini, C. Orlando, G. B. Vannelli, A. Aversa, A. Natali, et al.
Androgens Regulate Phosphodiesterase Type 5 Expression and Functional Activity in Corpora Cavernosa
Endocrinology, May 1, 2004; 145(5): 2253 - 2263.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by The American Society of Andrology.